Advertisement
American Journal of Infection Control
Advanced SearchSave search
Major Article| Volume 44, ISSUE 11, P1280-1284, November 01, 2016

Extensively drug-resistant Acinetobacter baumannii outbreak cross-transmitted in an intensive care unit and respiratory intensive care unit

  • Author Footnotes
    1 J.L. and S.H. contributed equally to this work.
    Jin'e Lei
    Footnotes
    1 J.L. and S.H. contributed equally to this work.
    Affiliations
    Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China

    Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China

    Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
    Search for articles by this author
  • Author Footnotes
    1 J.L. and S.H. contributed equally to this work.
    Shaoshan Han
    Footnotes
    1 J.L. and S.H. contributed equally to this work.
    Affiliations
    Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
    Search for articles by this author
  • Wenjing Wu
    Affiliations
    Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
    Search for articles by this author
  • Xue Wang
    Affiliations
    Intensive Care Unit, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
    Search for articles by this author
  • Jiru Xu
    Affiliations
    Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China

    Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China
    Search for articles by this author
  • Lei Han
    Correspondence
    Address correspondence to Lei Han, PhD, Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 W Yanta Rd, Xi'an 710061, China. (L. Han).
    Affiliations
    Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China

    Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China
    Search for articles by this author
  • Author Footnotes
    1 J.L. and S.H. contributed equally to this work.
Published:May 20, 2016DOI:https://doi.org/10.1016/j.ajic.2016.03.041
Extensively drug-resistant Acinetobacter baumannii outbreak cross-transmitted in an intensive care unit and respiratory intensive care unit
Previous ArticleClinical and economic impact of meropenem resistance in Pseudomonas aeruginosa–infected patients
Next ArticleEpidemiologic characteristics, clinical manifestations, and risk factors of 139 patients with Ebola virus disease in western Sierra Leone

      Highlights

      • •
        We describe an extensively drug-resistant Acinetobacter baumannii outbreak cross-transmitted between an intensive care unit and respiratory intensive care unit.
      • •
        The laminar flow system connecting the intensive care unit and respiratory intensive care unit was the source of transmission.
      • •
        The outbreak terminated after thorough cleaning, including the laminar flow system.

      Background

      Extensively drug-resistant Acinetobacter baumannii (XDRAB) is a great threat in intensive care units (ICUs). The aim of this study was to describe an XDRAB outbreak which was cross-transmitted in the ICU and respiratory intensive care unit (RICU) in a tertiary care hospital from January-March 2013.

      Methods

      Patient and environmental surveillances were performed. Isolates were tested for antimicrobial susceptibility. Genotypes were analyzed by multilocus sequence typing (MLST). A series of enhanced strategies were implemented to control the outbreak.

      Results

      A total of 11 patients were infected by XDRAB strains during this outbreak. Three patients in the ICU were found positive for XDRAB at the onset of the outbreak. Thereafter, infections were detected in 6 patients in the RICU, followed by reappearance of this strain in the ICU in 2 patients. All A baumannii strains isolated from patients and the environment were extensively drug resistant. MLST revealed them as ST368. After 3 rounds of environmental screening and cleaning, the laminar flow system connecting the ICU and RICU was found as the source of transmission. Successful control of this outbreak was achieved through multifaceted intervention measures.

      Conclusions

      This study suggested the importance of thorough surveillance and disinfection of the environment, including concealed devices, in preventing the transmission of an outbreak.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Karageorgopoulos D.E.
        • Falagas M.E.
        Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.
        Lancet Infect Dis. 2008; 8: 751-762
        View in Article
        • Peleg A.Y.
        • Seifert H.
        • Paterson D.L.
        Acinetobacter baumannii: emergence of a successful pathogen.
        Clin Microbiol Rev. 2008; 21: 538-582
        View in Article
        • Espinal P.
        • Macia M.D.
        • Roca I.
        • Gato E.
        • Ruiz E.
        • Fernandez-Cuenca F.
        • et al.
        First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.
        Antimicrob Agents Chemother. 2013; 57: 589-591
        View in Article
        • Cristina M.L.
        • Spagnolo A.M.
        • Ottria G.
        • Sartini M.
        • Orlando P.
        • Perdelli F.
        Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital.
        Am J Infect Control. 2011; 39: 790-794
        View in Article
        • Kohlenberg A.
        • Brummer S.
        • Higgins P.G.
        • Sohr D.
        • Piening B.C.
        • de Grahl C.
        • et al.
        Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.
        J Med Microbiol. 2009; 58: 1499-1507
        View in Article
        • Magiorakos A.P.
        • Srinivasan A.
        • Carey R.B.
        • Carmeli Y.
        • Falagas M.E.
        • Giske C.G.
        • et al.
        Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
        Clin Microbiol Infect. 2012; 18: 268-281
        View in Article
        • Higgins P.G.
        • Wisplinghoff H.
        • Krut O.
        • Seifert H.
        A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU.
        Clin Microbiol Infect. 2007; 13: 1199-1201
        View in Article
        • CLSI
        Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition (M07-A9).
        CLSI, Wayne (PA)2012
        View in Article
        • Livermore D.M.
        • Hope R.
        • Brick G.
        • Lillie M.
        • Reynolds R.
        Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.
        J Antimicrob Chemother. 2008; 62: ii55-63
        View in Article
        • Rossolini G.M.
        • Mantengoli E.
        Antimicrobial resistance in Europe and its potential impact on empirical therapy.
        Clin Microbiol Infect. 2008; 14: 2-8
        View in Article
        • Morgan D.J.
        • Weisenberg S.A.
        • Augenbraun M.H.
        • Calfee D.P.
        • Currie B.P.
        • Furuya E.Y.
        • et al.
        Multidrug-resistant Acinetobacter baumannii in New York City—10 years into the epidemic.
        Infect Control Hosp Epidemiol. 2009; 30: 196-197
        View in Article
        • Vilacoba E.
        • Almuzara M.
        • Gulone L.
        • Rodriguez R.
        • Pallone E.
        • Bakai R.
        • et al.
        Outbreak of extensively drug-resistant Acinetobacter baumannii indigo-pigmented strains.
        J Clin Microbiol. 2013; 51: 3726-3730
        View in Article
        • Zarrilli R.
        • Di Popolo A.
        • Bagattini M.
        • Giannouli M.
        • Martino D.
        • Barchitta M.
        • et al.
        Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy.
        J Hosp Infect. 2012; 82: 260-265
        View in Article
        • Viehman J.A.
        • Nguyen M.H.
        • Doi Y.
        Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.
        Drugs. 2014; 74: 1315-1333
        View in Article
        • Roca I.
        • Espinal P.
        • Vila-Farres X.
        • Vila J.
        The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace.
        Front Microbiol. 2012; 3: 148
        View in Article
        • Manchanda V.
        • Sanchaita S.
        • Singh N.
        Multidrug resistant Acinetobacter.
        J Glob Infect Dis. 2010; 2: 291-304
        View in Article
        • Ye D.
        • Shan J.
        • Huang Y.
        • Li J.
        • Li C.
        • Liu X.
        • et al.
        A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China.
        BMC Infect Dis. 2015; 15: 179
        View in Article
        • Liang W.
        • Liu X.F.
        • Huang J.
        • Zhu D.M.
        • Li J.
        • Zhang J.
        Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.
        BMC Infect Dis. 2011; 11: 109
        View in Article
        • Wareham D.W.
        • Gordon N.C.
        • Hornsey M.
        In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii.
        J Antimicrob Chemother. 2011; 66: 1047-1051
        View in Article
        • Gordon N.C.
        • Png K.
        • Wareham D.W.
        Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.
        Antimicrob Agents Chemother. 2010; 54: 5316-5322
        View in Article
        • Principe L.
        • D'Arezzo S.
        • Capone A.
        • Petrosillo N.
        • Visca P.
        In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
        Ann Clin Microbiol Antimicrob. 2009; 8: 18
        View in Article
        • Ozbek B.
        • Senturk A.
        Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
        Chemotherapy. 2010; 56: 466-471
        View in Article
        • Wei W.
        • Yang H.
        • Liu Y.
        • Ye Y.
        • Li J.
        In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.
        J Chemother. 2016; (in press)https://doi.org/10.1179/1973947815Y.0000000030
        View in Article
        • Inchai J.
        • Liwsrisakun C.
        • Theerakittikul T.
        • Chaiwarith R.
        • Khositsakulchai W.
        • Pothirat C.
        Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a medical intensive care unit of university hospital in Thailand.
        J Infect Chemother. 2015; 21: 570-574
        View in Article
        • Akajagbor D.S.
        • Wilson S.L.
        • Shere-Wolfe K.D.
        • Dakum P.
        • Charurat M.E.
        • Gilliam B.L.
        Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
        Clin Infect Dis. 2013; 57: 1300-1303
        View in Article
        • Markogiannakis A.
        • Fildisis G.
        • Tsiplakou S.
        • Ikonomidis A.
        • Koutsoukou A.
        • Pournaras S.
        • et al.
        Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
        Infect Control Hosp Epidemiol. 2008; 29: 410-417
        View in Article

      Article Info

      Publication History

      Published online: May 20, 2016

      Footnotes

      Funding/Support: This work was supported by the Research Fund of Xi'an Jiaotong University ( DW081135K0000004 ).

      Conflicts of Interest: None to report.

      Identification

      DOI: https://doi.org/10.1016/j.ajic.2016.03.041

      Copyright

      © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX